rts logo

What should you know before buying stock in Abbott Laboratories (ABT)

Abbott Laboratories (NYSE: ABT) is -7.66% lower on its value in year-to-date trading and has touched a low of $89.67 and a high of $121.64 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ABT stock was last observed hovering at around $102.12 in the last trading session, with the day’s loss setting it -0.48%.

Currently trading at $101.64, the stock is -2.79% and -2.74% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.27 million and changing -0.47% at the moment leaves the stock -4.40% off its SMA200. ABT registered -4.43% loss for a year compared to 6-month loss of -8.27%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a -2.52% gain in the last 1 month and extending the period to 3 months gives it a -8.03%, and is -1.51% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.62% over the week and 1.74% over the month.

Abbott Laboratories (ABT) has around 114000 employees, a market worth around $176.82B and $40.33B in sales. Current P/E ratio is 31.66 and Fwd P/E is 19.80. Profit margin for the company is 13.91%. Distance from 52-week low is 13.34% and -16.44% from its 52-week high. The company has generated returns on investments over the last 12 months (10.92%).

The EPS is expected to grow by 4.22% this year.

Abbott Laboratories (ABT) Top Institutional Holders

The shares outstanding are 1.73B, and float is at 1.73B with Short Float at 0.67%.

Abbott Laboratories (ABT) Insider Activity

The most recent transaction is an insider sale by Funck, Jr. Robert E.,the company’sEXECUTIVE VICE PRESIDENT. SEC filings show that Funck, Jr. Robert E. sold 10,097 shares of the company’s common stock on May 10 ’24 at a price of $104.57 per share for a total of $1.06 million. Following the sale, the insider now owns 0.21 million shares.

Abbott Laboratories disclosed in a document filed with the SEC on May 07 ’24 that Earnhardt Lisa D (EXECUTIVE VICE PRESIDENT) sold a total of 22,852 shares of the company’s common stock. The trade occurred on May 07 ’24 and was made at $106.25 per share for $2.43 million. Following the transaction, the insider now directly holds 61462.0 shares of the ABT stock.

Still, SEC filings show that on Mar 01 ’24, Salvadori Daniel Gesua Sive (EXECUTIVE VICE PRESIDENT) disposed off 963 shares at an average price of $118.50 for $0.11 million. The insider now directly holds 125,697 shares of Abbott Laboratories (ABT).

Related Posts